Retinol-binding protein 4 in human obesity

Area of Science:

• Metabolic regulation
• Adipocyte biology
• Human physiology

Background:

• Rodent studies suggest adipocytes regulate glucose metabolism via retinol-binding protein 4 (RBP4).
• This mechanism requires validation in human subjects.
• Retinol-binding protein 4 (RBP4) is implicated in glucose homeostasis.

Purpose of the Study:

• To investigate the role of RBP4 in human glucose metabolism.
• To compare RBP4 regulation in human adipocytes with rodent models.
• To assess the relationship between RBP4, obesity, and glucose levels in humans.

Main Methods:

• Analysis of RBP4 expression and secretion in isolated human adipocytes.
• Measurement of RBP4 mRNA in subcutaneous adipose tissue from women of varying weights.
• Quantification of serum RBP4 concentrations.
• Correlation analysis with GLUT4 expression and body mass index.
• Microdialysis to assess interstitial glucose and RBP4 in relation to glucose tolerance.

Main Results:

• RBP4 was expressed and secreted by human adipocytes, but its mRNA was downregulated in obese women.
• Circulating RBP4 levels were similar across normal weight, overweight, and obese individuals.
• Adipose RBP4 expression correlated positively with GLUT4, independent of obesity.
• Weight loss minimally affected adipose RBP4 and did not alter circulating RBP4.
• No significant differences in RBP4 expression or serum levels were found between groups with high vs. low interstitial glucose.

Conclusions:

• Human RBP4 regulation in adipose tissue and circulation differs significantly from rodents.
• The proposed model of adipocyte glucose sensing via RBP4 release may not apply to humans.
• Adipose RBP4's role in human glucose metabolism appears independent of obesity and interstitial glucose levels.